These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. TNF-alpha and homocysteine levels in type 1 diabetes mellitus. Abdel Aziz MT; Fouad HH; Mohsen GA; Mansour M; Abdel Ghaffar S East Mediterr Health J; 2001; 7(4-5):679-88. PubMed ID: 15332766 [TBL] [Abstract][Full Text] [Related]
5. Mechanisms of the atherogenic effects of elevated homocysteine in experimental models. Wilson KM; Lentz SR Semin Vasc Med; 2005 May; 5(2):163-71. PubMed ID: 16047268 [TBL] [Abstract][Full Text] [Related]
6. [Chronic complication of diabetes and homocysteine]. Idzior-Waluś B; Cieślik G Przegl Lek; 2000; 57(12):732-5. PubMed ID: 11398598 [TBL] [Abstract][Full Text] [Related]
7. Impact of Diabetes on Homocysteine Levels and Its Relationship with Coronary Artery Disease: A Single-Centre Cohort Study. Schaffer A; Verdoia M; Barbieri L; Cassetti E; Suryapranata H; De Luca G Ann Nutr Metab; 2016; 68(3):180-8. PubMed ID: 26950830 [TBL] [Abstract][Full Text] [Related]
9. Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2. de Luis DA; Fernandez N; Arranz ML; Aller R; Izaola O; Romero E J Diabetes Complications; 2005; 19(1):42-6. PubMed ID: 15642489 [TBL] [Abstract][Full Text] [Related]
10. Plasma homocysteine and microvascular complications in type 1 diabetes. Vaccaro O; Perna AF; Mancini FP; Iovine C; Cuomo V; Sacco M; Tufano A; Rivellese AA; Ingrosso D; Riccardi G Nutr Metab Cardiovasc Dis; 2000 Dec; 10(6):297-304. PubMed ID: 11302003 [TBL] [Abstract][Full Text] [Related]
11. [Clinical relevance of homocysteine monitoring in the diabetic patient]. Benmerabet S; Fredenrich A; Robillon JF; Canivet B; Candito M; Van Obberghen E Diabetes Metab; 2002 Dec; 28(6 Pt 1):510-5. PubMed ID: 12522334 [TBL] [Abstract][Full Text] [Related]
12. [Homocysteine and diabetic macroangiopathy]. Araki A Nihon Rinsho; 2006 Nov; 64(11):2153-8. PubMed ID: 17087311 [TBL] [Abstract][Full Text] [Related]
13. To: Looker HC, Fagot-Campagna A, Gunter EW et al. (2003) Homocysteine as a risk factor for nephropathy and retinopathy in Type 2 diabetes. Diabetologia 46:766-772. Shukla N; Angelini GD; Jeremy JY Diabetologia; 2004 Jan; 47(1):140-1. PubMed ID: 14628110 [No Abstract] [Full Text] [Related]
15. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease? Chico A; Pérez A; Córdoba A; Arcelús R; Carreras G; de Leiva A; González-Sastre F; Blanco-Vaca F Diabetologia; 1998 Jun; 41(6):684-93. PubMed ID: 9662051 [TBL] [Abstract][Full Text] [Related]
19. Relationship between plasma homocysteine and the morphological and immunohistochemical study of carotid plaques in patients with carotid stenosis over 70%. Alvarez B; Yugueros X; Fernández E; Luccini F; Gené A; Matas M Ann Vasc Surg; 2012 May; 26(4):500-5. PubMed ID: 22520390 [TBL] [Abstract][Full Text] [Related]
20. Plasmatic homocysteine concentration and its relationship with complications associated to diabetes mellitus. Agulló-Ortuño MT; Albaladejo MD; Parra S; Rodríguez-Manotas M; Fenollar M; Ruíz-Espejo F; Tebar J; Martínez P Clin Chim Acta; 2002 Dec; 326(1-2):105-12. PubMed ID: 12417101 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]